tiprankstipranks
Trending News
More News >
Austar Lifesciences Ltd. (HK:6118)
:6118
Hong Kong Market

Austar Lifesciences Ltd. (6118) Price & Analysis

Compare
0 Followers

6118 Stock Chart & Stats


Financials

6118 FAQ

What was Austar Lifesciences Ltd.’s price range in the past 12 months?
Austar Lifesciences Ltd. lowest stock price was HK$0.45 and its highest was HK$1.10 in the past 12 months.
    What is Austar Lifesciences Ltd.’s market cap?
    Austar Lifesciences Ltd.’s market cap is HK$348.56M.
      When is Austar Lifesciences Ltd.’s upcoming earnings report date?
      Austar Lifesciences Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 87 days.
        How were Austar Lifesciences Ltd.’s earnings last quarter?
        Austar Lifesciences Ltd. released its earnings results on Mar 26, 2025. The company reported HK$0.022 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.022.
          Is Austar Lifesciences Ltd. overvalued?
          According to Wall Street analysts Austar Lifesciences Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Austar Lifesciences Ltd. pay dividends?
            Austar Lifesciences Ltd. pays a Notavailable dividend of HK$0.05 which represents an annual dividend yield of N/A. See more information on Austar Lifesciences Ltd. dividends here
              What is Austar Lifesciences Ltd.’s EPS estimate?
              Austar Lifesciences Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Austar Lifesciences Ltd. have?
              Austar Lifesciences Ltd. has 512,582,030 shares outstanding.
                What happened to Austar Lifesciences Ltd.’s price movement after its last earnings report?
                Austar Lifesciences Ltd. reported an EPS of HK$0.022 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.529%.
                  Which hedge fund is a major shareholder of Austar Lifesciences Ltd.?
                  Currently, no hedge funds are holding shares in HK:6118

                  Austar Lifesciences Ltd. Stock Smart Score

                  6
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  -9.33%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  2.06%
                  Trailing 12-Months
                  Asset Growth
                  -6.71%
                  Trailing 12-Months

                  Company Description

                  Austar Lifesciences Ltd.

                  Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Shanghai Fosun Pharmaceutical (Group) Co
                  3SBio
                  Wuxi Biologics (Cayman)
                  Ascletis Pharma, Inc.
                  Viva Biotech Holdings
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis